BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 18172258)

  • 21. Serum protein profile analysis in patients with head and neck squamous cell carcinoma.
    Gourin CG; Xia ZS; Han Y; French AM; O'Rourke AK; Terris DJ; Adam BL
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):390-7. PubMed ID: 16618908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma.
    Chang HW; Ling GS; Wei WI; Yuen AP
    Cancer; 2004 Jul; 101(1):125-32. PubMed ID: 15221997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma.
    Nagata S; Hamada T; Yamada N; Yokoyama S; Kitamoto S; Kanmura Y; Nomura M; Kamikawa Y; Yonezawa S; Sugihara K
    Cancer; 2012 Sep; 118(17):4298-308. PubMed ID: 22252571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients.
    Battagli C; Uzzo RG; Dulaimi E; Ibanez de Caceres I; Krassenstein R; Al-Saleem T; Greenberg RE; Cairns P
    Cancer Res; 2003 Dec; 63(24):8695-9. PubMed ID: 14695183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Xu GW; Deng GR
    Ai Zheng; 2007 Jan; 26(1):44-7. PubMed ID: 17222366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates.
    Nieuwenhuis EJ; Jaspars LH; Castelijns JA; Bakker B; Wishaupt RG; Denkers F; Leemans CR; Snow GB; Brakenhoff RH
    Clin Cancer Res; 2003 Feb; 9(2):755-61. PubMed ID: 12576446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing.
    Shaw RJ; Akufo-Tetteh EK; Risk JM; Field JK; Liloglou T
    Nucleic Acids Res; 2006 Jun; 34(11):e78. PubMed ID: 16807314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LHX6 is a sensitive methylation marker in head and neck carcinomas.
    Estécio MR; Youssef EM; Rahal P; Fukuyama EE; Góis-Filho JF; Maniglia JV; Goloni-Bertollo EM; Issa JP; Tajara EH
    Oncogene; 2006 Aug; 25(36):5018-26. PubMed ID: 16732332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Death-associated protein kinase promoter hypermethylation in normal human lymphocytes.
    Reddy AN; Jiang WW; Kim M; Benoit N; Taylor R; Clinger J; Sidransky D; Califano JA
    Cancer Res; 2003 Nov; 63(22):7694-8. PubMed ID: 14633692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salivary soluble CD44: a potential molecular marker for head and neck cancer.
    Franzmann EJ; Reategui EP; Carraway KL; Hamilton KL; Weed DT; Goodwin WJ
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):735-9. PubMed ID: 15767360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis.
    Spafford MF; Koch WM; Reed AL; Califano JA; Xu LH; Eisenberger CF; Yip L; Leong PL; Wu L; Liu SX; Jerónimo C; Westra WH; Sidransky D
    Clin Cancer Res; 2001 Mar; 7(3):607-12. PubMed ID: 11297256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients.
    Nakayama G; Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
    Anticancer Res; 2007; 27(3B):1459-63. PubMed ID: 17595762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer.
    Sun W; Zaboli D; Wang H; Liu Y; Arnaoutakis D; Khan T; Khan Z; Koch WM; Califano JA
    Clin Cancer Res; 2012 Feb; 18(4):1082-91. PubMed ID: 22228635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
    Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
    Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypermethylation of promoter region of RAS association domain family gene1A in esophageal squamous cell carcinoma and significance thereof].
    Cong DG; Wang SF
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2932-4. PubMed ID: 18261310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma.
    Hsiung DT; Marsit CJ; Houseman EA; Eddy K; Furniss CS; McClean MD; Kelsey KT
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):108-14. PubMed ID: 17220338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
    Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
    Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter methylation of cyclin A1 is associated with human papillomavirus 16 induced head and neck squamous cell carcinoma independently of p53 mutation.
    Weiss D; Basel T; Sachse F; Braeuninger A; Rudack C
    Mol Carcinog; 2011 Sep; 50(9):680-8. PubMed ID: 21563216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing.
    Tokumaru Y; Yamashita K; Osada M; Nomoto S; Sun DI; Xiao Y; Hoque MO; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Sep; 64(17):5982-7. PubMed ID: 15342377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.